RANI THERAPEUTICS
Rani is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics, which we believe will have the potential to transform medicine and improve patient outcomes. We have developed the RaniPill capsule, which is our novel, proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The RaniPill capsule is an orally ingestible pill approximately the size of a “000” c... apsule (or similar to the size of a standard fish oil or calcium pill) that is designed to automatically administer a precise therapeutic dose of medication upon deployment in the small intestine. To date, we have successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using the RaniPill capsule. Our development efforts have enabled us to construct an extensive intellectual property portfolio that we believe provides us a competitive advantage.
RANI THERAPEUTICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
San Jose, California, United States
Country:
United States
Website Url:
http://www.ranitherapeutics.com
Total Employee:
51+
Status:
Active
Contact:
(408) 457 3730
Total Funding:
256.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Current Advisors List
Board_member
2012-06-01
Current Employees Featured
Mir Imran Chairman & CEO @ Rani Therapeutics
Chairman & CEO
2012-06-01
Syed Zaidi Vice President, Finance & Operations @ Rani Therapeutics
Vice President, Finance & Operations
Mir Hashim Vice President, Research & Development @ Rani Therapeutics
Vice President, Research & Development
Svai Sanford Chief Financial Officer @ Rani Therapeutics
Chief Financial Officer
Talat Imran Chief Executive Officer @ Rani Therapeutics
Chief Executive Officer
2021-06-01
Bob Gaffney Vice President, Operations @ Rani Therapeutics
Vice President, Operations
Founder
Stock Details
Investors List
Shire
Shire investment in Venture Round - Rani Therapeutics
Virtus Inspire Ventures
Virtus Inspire Ventures investment in Venture Round - Rani Therapeutics
Cathay Venture
Cathay Venture investment in Venture Round - Rani Therapeutics
Bossa Ventures
Bossa Ventures investment in Venture Round - Rani Therapeutics
Novartis
Novartis investment in Venture Round - Rani Therapeutics
Ping An Ventures
Ping An Ventures investment in Venture Round - Rani Therapeutics
AstraZeneca
AstraZeneca investment in Venture Round - Rani Therapeutics
GeneScience Pharmaceuticals
GeneScience Pharmaceuticals investment in Venture Round - Rani Therapeutics
GV
GV investment in Venture Round - Rani Therapeutics
GV
GV investment in Series D - Rani Therapeutics
Newest Events participated
Official Site Inspections
http://www.ranitherapeutics.com Semrush global rank: 2.38 M Semrush visits lastest month: 7.75 K
- Host name: 104.21.8.97
- IP address: 104.21.8.97
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Rani Therapeutics"
Our Team - Rani Therapeutics
CHI is an independent 501(c)(6) organization devoted to researching and advocating policy to forward the interests of California’s biomedical community. Jean-Luc Butel Director at Takeda, Novo Holdings, and SG Innovate. Jean …See details»
Investor Relations - Rani Therapeutics, LLC
Nov 18, 2024 Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to …See details»
About Us - Rani Therapeutics
© Rani Therapeutics. All Rights Reserved. Rani, Rani Therapeutics, and RaniPill and their corresponding logos are trademarks or registered trademarks of Rani ...See details»
Rani Therapeutics - Crunchbase Company Profile & Funding
Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes. They developed the RaniPill capsule, …See details»
Rani Therapeutics - LinkedIn
Rani Therapeutics is a clinical-stage biotech company that has developed a platform technology to enable oral delivery of biologic drugs. Millions of patients with chronic conditions require ...See details»
Rani Therapeutics Holdings, Inc. (RANI) - Yahoo Finance
See the company profile for Rani Therapeutics Holdings, Inc. (RANI) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Rani Therapeutics Holdings (RANI) Company Profile & Description
Jul 30, 2021 Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally …See details»
Rani Therapeutics LLC
For more information, visit ranitherapeutics.com. Investor Contact:investors@ranitherapeutics.com Media Contact:media@ranitherapeutics.com . 15 Oct …See details»
News Release - Rani Therapeutics, LLC
For more information, visit www.ranitherapeutics.com. Forward-Looking Statements. Statements contained in this press release regarding matters that are not historical facts are “forward …See details»
Working At Rani Therapeutics: Company Overview and Culture
Www.ranitherapeutics.com. Organization Type. Public. Rani Therapeutics, LLC develops a oral biotherapeutics technology for the oral delivery of large drug molecules, including peptides, …See details»
Rani Therapeutics - PitchBook
Rani Therapeutics General Information Description. Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally …See details»
Rani Therapeutics - Craft
Oct 29, 2024 Rani Therapeutics has 1 employees at their 1 location and $2.72 m in annual revenue in FY 2021. See insights on Rani Therapeutics including office locations, competitors, …See details»
Our Story - Rani Therapeutics
Our Mission. Our mission is to improve the lives of millions of patients suffering from chronic conditions by replacing painful injections with a pill designed to minimize GI discomfort.See details»
Rani Therapeutics - Overview, News & Similar companies - ZoomInfo
Jun 21, 2023 www.ranitherapeutics.com. Revenue <$5 Million. Stock Symbol RANI. Industry Pharmaceuticals Healthcare . Recent News & Media. Rani Therapeutics Holdings, Inc. (RANI) …See details»
Rani Therapeutics Announces Research Agreement with Chugai
1 hour ago For more information, visit ranitherapeutics.com. About Chugai Pharmaceutical . Chugai Pharmaceutical Co., Ltd., headquartered in Tokyo, is a research-based …See details»
Rani Therapeutics Enters Research Agreement with Chugai
4 hours ago capsule technology. For more information, visit ranitherapeutics.com. About Chugai Pharmaceutical. Chugai Pharmaceutical Co., Ltd., headquartered in Tokyo, is a research …See details»
News Release - Rani Therapeutics, LLC
For more information, visit ranitherapeutics.com. Forward-Looking Statements. Statements contained in this press release regarding matters that are not historical facts are “forward …See details»
News Release - ir.ranitherapeutics.com
SAN JOSE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company …See details»
Rani Therapeutics Announces Research Agreement with Chugai
4 hours ago - Research agreement is evaluating feasibility of applying Rani’s oral delivery technology to Chugai’s antibodies against undisclosed targets - SAN JOSE, Calif., May 19, …See details»
Rani Therapeutics Announces Research Agreement with Chugai
4 hours ago For more information, visit ranitherapeutics.com. About Chugai Pharmaceutical . Advertisement. Chugai Pharmaceutical Co., Ltd., headquartered in Tokyo, is a research-based …See details»